| 今开：2.84 | 昨收：2.85 |
| 最高：2.9575 | 最低：2.76 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.56630841E8 |
Mersana Therapeutics(MRSN)01-30 04:35
$Mersana Therapeutics(MRSN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-005088 Act: 34 Size: 13 KB 网页链接查看全文
Mersana Therapeutics(MRSN)02-15 08:05
$Mersana Therapeutics(MRSN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-24-000155 Act: 34 Size: 61 KB 网页链接查看全文
Mersana Therapeutics(MRSN)02-28 20:15
$Mersana Therapeutics(MRSN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-24-028467 Act: 34 Size: 263 KB 网页链接查看全文
Mersana Therapeutics(MRSN)02-28 21:45
$Mersana Therapeutics(MRSN)$ POSASR Post-effective Amendment to an automatic shelf registration statement Accession Number: 0001104659-24-028509 Act: 33 Size: 420 KB 网页链接查看全文
Mersana Therapeutics(MRSN)02-29 05:15
$Mersana Therapeutics(MRSN)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-24-028705 Act: 33 Size: 315 KB 网页链接查看全文
Mersana Therapeutics(MRSN)04-04 08:25
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043261 Size: 5 KB 网页链接查看全文
Mersana Therapeutics(MRSN)04-26 18:15
$Mersana Therapeutics(MRSN)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-052235 Act: 34 Size: 2 MB 网页链接查看全文
Mersana Therapeutics(MRSN)02-15 10:05
$Mersana Therapeutics(MRSN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024238 Act: 34 Size: 155 KB 网页链接查看全文
Mersana Therapeutics(MRSN)02-17 05:35
$Mersana Therapeutics(MRSN)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-024929 Size: 4 KB 网页链接查看全文
Mersana Therapeutics(MRSN)04-26 18:35
$Mersana Therapeutics(MRSN)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-052299 Act: 34 Size: 3 MB 网页链接查看全文
淘沙见金2018-06-03 12:45
有空可以看看 $Mersana Therapeutics, Inc.(MRSN)$ 的数据，早期了一些不该应该比Daiichi Sankyo的DS-8201在安全性方面好一些。查看全文
群氓鄙陋2018-05-16 10:10
$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 乳腺癌药物美股标的Mark！谢谢楼主的无私分享查看全文
淘沙见金2018-05-15 12:06
$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 今年ASCO乳腺癌重点关注的几家。其中ZYME的HER2靶向双特异性抗体和MRSN的XMT-1522是重点关注的对象。查看全文
iam双手反拍2017-10-13 15:03
$Mersana Therapeutics, Inc.(MRSN)$ 在新一代ADC技术的道路上，美国的Mersana并非独行者和技术垄断者。我国的诺灵生物医药科技（北京）有限公司（简称“诺灵”）也掌握了高分子偶联技术，其自主知识产权的技术平台与Mersana相比，不但毫不逊色，而且在药物代谢控制、药物释放方面更优。诺灵的ADC...查看全文
iam双手反拍2017-10-13 14:29
$Mersana Therapeutics, Inc.(MRSN)$
“在新一代ADC技术的道路上，美国的Mersana并非独行者和技术垄断者。我国的诺灵生物医药科技（北京）有限公司（简称“诺灵”）也掌握了高分子偶联技术，其自主知识产权的技术平台与Mersana相比，不但毫不逊色，而且在药物代谢控制、药物释放方面更优。诺灵...查看全文
$Mersana Therapeutics(MRSN)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-052299 Act: 34 Size: 3 MB 网页链接
$Mersana Therapeutics(MRSN)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-052235 Act: 34 Size: 2 MB 网页链接
$Mersana Therapeutics(MRSN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-052250 Act: 34 Size: 396 KB 网页链接
$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043261 Size: 5 KB 网页链接
$Mersana Therapeutics(MRSN)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-24-028705 Act: 33 Size: 315 KB 网页链接
$Mersana Therapeutics(MRSN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-028709 Act: 33 Size: 346 KB 网页链接
$Mersana Therapeutics(MRSN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-028715 Act: 34 Size: 547 KB 网页链接
$Mersana Therapeutics(MRSN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-007407 Act: 34 Size: 10 MB 网页链接
$Mersana Therapeutics(MRSN)$ POSASR Post-effective Amendment to an automatic shelf registration statement Accession Number: 0001104659-24-028509 Act: 33 Size: 420 KB 网页链接
$Mersana Therapeutics(MRSN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-24-028467 Act: 34 Size: 263 KB 网页链接